Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Elewaut

Showing results (41-50 of 299) with videos related to

Pageof 30
Sort By:
Annals of the Rheumatic Diseases|December 1, 2011
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modificationGust Verbruggen, Ruth Wittoek, Bert Vander Cruyssen, et al.
Rheumatic Diseases Clinics of North America|April 29, 2020
Intestinal Microbiota, HLA-B27, and Spondyloarthritis: Dangerous LiaisonsEmilie Dumas, Koen Venken, James T Rosenbaum, et al.
Annals of the Rheumatic Diseases|December 2, 2009
Morbid anatomy of 'erosive osteoarthritis' of the interphalangeal finger joints: an optimised scoring system to monitor disease progression in affected jointsGust Verbruggen, Ruth Wittoek, Bert Vander Cruyssen, et al.
Best Practice & Research. Clinical Rheumatology|December 10, 2014
The role of the gut and microbes in the pathogenesis of spondyloarthritisMark Asquith, Dirk Elewaut, Phoebe Lin, et al.
Current Opinion in Rheumatology|May 21, 2014
Relevance of the gut/joint axis for the management of spondyloarthritis in daily clinical practiceHeleen Cypers, Liesbet Van Praet, Gaëlle Varkas, et al.
Bioorganic & Medicinal Chemistry|November 6, 2012
Synthesis of 6"-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligandsNora Pauwels, Sandrine Aspeslagh, Dirk Elewaut, et al.
Annals of the Rheumatic Diseases|May 30, 2020
Response to: 'Finding the right one' by ZanwarThomas Renson, Filip E Van den Bosch, Dirk Elewaut
Best Practice & Research. Clinical Rheumatology|May 6, 2008
Spondyloarthropathies: progress and challengesPeggy Jacques, Herman Mielants, Martine De Vos, et al.
Rheumatology (Oxford, England)|May 7, 2021
Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and jointsZuzanna Łukasik, Eric Gracey, Koen Venken, et al.
Oncotarget|February 20, 2016
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Mérédis Favreau, Karin Vanderkerken, Dirk Elewaut, et al.
Pageof 30

Showing results (41-50 of 299) with videos related to

Sort By:
Pageof 30
Annals of the Rheumatic Diseases|December 1, 2011
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modificationGust Verbruggen, Ruth Wittoek, Bert Vander Cruyssen, et al.
Rheumatic Diseases Clinics of North America|April 29, 2020
Intestinal Microbiota, HLA-B27, and Spondyloarthritis: Dangerous LiaisonsEmilie Dumas, Koen Venken, James T Rosenbaum, et al.
Annals of the Rheumatic Diseases|December 2, 2009
Morbid anatomy of 'erosive osteoarthritis' of the interphalangeal finger joints: an optimised scoring system to monitor disease progression in affected jointsGust Verbruggen, Ruth Wittoek, Bert Vander Cruyssen, et al.
Best Practice & Research. Clinical Rheumatology|December 10, 2014
The role of the gut and microbes in the pathogenesis of spondyloarthritisMark Asquith, Dirk Elewaut, Phoebe Lin, et al.
Current Opinion in Rheumatology|May 21, 2014
Relevance of the gut/joint axis for the management of spondyloarthritis in daily clinical practiceHeleen Cypers, Liesbet Van Praet, Gaëlle Varkas, et al.
Bioorganic & Medicinal Chemistry|November 6, 2012
Synthesis of 6"-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligandsNora Pauwels, Sandrine Aspeslagh, Dirk Elewaut, et al.
Annals of the Rheumatic Diseases|May 30, 2020
Response to: 'Finding the right one' by ZanwarThomas Renson, Filip E Van den Bosch, Dirk Elewaut
Best Practice & Research. Clinical Rheumatology|May 6, 2008
Spondyloarthropathies: progress and challengesPeggy Jacques, Herman Mielants, Martine De Vos, et al.
Rheumatology (Oxford, England)|May 7, 2021
Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and jointsZuzanna Łukasik, Eric Gracey, Koen Venken, et al.
Oncotarget|February 20, 2016
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Mérédis Favreau, Karin Vanderkerken, Dirk Elewaut, et al.
Pageof 30